Susan Hasty, Publisher
Table of Contents . . . March 1st, 1999Non-Subscriber - Summaries Only
Vaccination (HBV) - Taiwan Experience Shows Universal Immunization is Best
Proteomics - Structural Proteins vp4 and 2a Influence Hepatitis A
Proteomics (HCV) - Hepatitis C NS3 Protein Studied
Testing (HCV) - Whole-Blood Assay is More Sensitive Than Plasma
Therapy (HCV) - No Efficacy Difference Seen with Increasing IFN Dosage
Vaccines - Combined HBV/Flu Vaccine is Cost Effective
Vaccines (HAV) - Long-Term Follow-Up of HAV Immunizations Reported
Vaccines (HBV) - Response to pre-S/S Vaccine Influenced by Genotype
Virology (HAV) - MRC-5 Cells are Rate-Limiting for Hepatitis A Replication
Transplants - Mortality Higher in Renal Transplants with Hepatitis
Industry News (Diagnostics) - U.S. FDA Approval Granted for HCV Test
Liver Cancer (Therapy) - Researchers Prove Chemoprevention Can Work
Pediatrics (Hepatitis A) - CDC Panel Urges Mandatory Hepatitis Shots for Children
Drug Development (Antivirals) - "Nucleosides With Dual AntiHIV and HBV Activity."
Diagnostics (HCV) - "Peptide Analysis in NS5 Only RIBA Indeterminate Sera."
Epidemiology (HCV) - "HCV Surrogates Among Blood Donors Implicated in HCV Transmission."
Vaccine Efficacy - "Methods for Evaluating Vaccine Efficacy."
HCV RNA Quantitation - "High-Throughput Real-Time Reverse Transcription PCR Quantitation of Hepatitis C Virus RNA."
HCV Therapy (Liver Transplantation) - "Rimantadine for Treatment of Hepatitis C Infection in Liver Transplant Recipients."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.